Skip to Content Facebook Feature Image

Metropolitan Commercial Bank Recognized Among America’s High Growth Companies 2026

Business

Metropolitan Commercial Bank Recognized Among America’s High Growth Companies 2026
Business

Business

Metropolitan Commercial Bank Recognized Among America’s High Growth Companies 2026

2026-07-15 19:05 Last Updated At:19:20

NEW YORK--(BUSINESS WIRE)--Jul 15, 2026--

Metropolitan Commercial Bank (“MCB” or the “Bank”) is proud to announce that it has been recognized among America’s High Growth Companies 2026, a distinction presented through a partnership between Business Insider and Plant-A Insights Group. This recognition highlights companies that have demonstrated exceptional growth, financial strength, and long-term stability while successfully creating value for shareholders and stakeholders.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715746434/en/

The America’s High Growth Companies 2026 ranking evaluated more than 3,000 publicly listed U.S. companies across a comprehensive set of financial and operational metrics. Companies were assessed on four key pillars: Financial Performance, Profitability Growth, Investor Value, and Stability, with only the 500 highest-scoring companies earning recognition.

“This recognition reflects the dedication of our bankers, the trust of our clients, and our commitment to financial excellence,” said Mark R. DeFazio, Founder, President and Chief Executive Officer of Metropolitan Commercial Bank. “At MCB, we remain focused on delivering exceptional banking solutions, fostering long-term relationships, and helping our clients build and sustain generational wealth.”

To determine the rankings, researchers reviewed public financial filings and evaluated eligible companies using 11 metrics spanning revenue growth, profitability, shareholder value, market performance, and financial stability. Only U.S.-headquartered companies listed on the NYSE or Nasdaq since 2020, with at least $100 million in revenue and profitability in fiscal year 2025, were considered.

The ranking’s methodology was designed to identify organizations capable of achieving sustained growth while maintaining strong financial fundamentals. In addition to financial analysis, companies underwent a rigorous media monitoring review to assess corporate governance and business integrity.

Metropolitan Commercial Bank continues to execute its strategic vision through a relationship-focused approach, modern banking solutions, and a commitment to helping clients achieve their financial goals.

This latest recognition underscores the Bank’s emphasis in innovation and excellence in every interaction.

About Metropolitan Commercial Bank

Metropolitan Commercial Bank (“MCB”) is a New York City–based, full-service commercial bank serving businesses, institutions, and individuals who value expertise, responsiveness, and long-term partnerships. Since 1999, MCB has built enduring client relationships—many spanning generations—by delivering consistent, relationship-driven banking.

The Bank provides a full suite of commercial, business, and personal banking solutions, with deep expertise in sectors including real estate, property management, legal services, healthcare, government, and global investors utilizing EB-5 financial solutions. MCB combines specialized capabilities with a highly personalized approach, offering integrated solutions such as title and escrow services, 1031 exchanges, and merchant acquiring.

MCB has received national recognition for its performance and innovation, including being named one of Newsweek’s Best Regional Banks in 2024 and 2025 and earning industry recognition for its lending performance and specialized commercial banking capabilities.

MCB operates full-service banking centers in Manhattan and Boro Park, Brooklyn, within New York City; Great Neck on Long Island; Lakewood, New Jersey; and in South Florida, including Miami, and West Palm Beach.

Metropolitan Commercial Bank is a New York State–chartered commercial bank, a member of the Federal Reserve System and the Federal Deposit Insurance Corporation, and an equal housing lender. The Bank’s parent company is Metropolitan Bank Holding Corp. (NYSE: MCB).

For more information, please visit the Bank’s website at MCBankNY.com.

Metropolitan Commercial Bank

Metropolitan Commercial Bank

BREMEN, Germany--(BUSINESS WIRE)--Jul 15, 2026--

Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER ® clinical metagenomics platform from Noscendo GmbH.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715763519/en/

DISQVER ® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker's NGS-based infection detection capabilities. Without any need for prior cultivation, DISQVER analyzes whole genome sequencing (WGS) data and applies advanced, proprietary bioinformatics to search for more than 11,000 different microbes and parasites. The mNGS analysis can be done directly from cell-free DNA samples from blood, in less than 24 hours after sample receipt. This advanced mNGS clinical research approach can be valuable for bloodstream infections, sepsis, endocarditis, and other severe infectious diseases.

Following the acquisition, DISQVER ® remains available for research use only, while Bruker is progressing its registration for diagnostic purposes. Financial details of the transaction were not disclosed, and DISQVER ® is not expected to be material to Bruker’s FY26 financial results.

Dr. Wolfgang Pusch, President of Bruker Microbiology & Infection Diagnostics, commented: “ The acquisition of the DISQVER®proprietary software and workflow platform is the latest step in our evolution as an innovative microbiology and molecular diagnostics business. We have expanded into rapid antimicrobial susceptibility testing (AST), hospital hygiene testing, sample-to-answer molecular diagnostics with the ELITech Genius platform, and most recently into NGS for infectious disease testing. DISQVER®adds additional NGS applications to our portfolio for metagenomics, and enhances our support for earlier decision-making in sepsis, bloodstream infections, and severe infections. "

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples

The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples

Recommended Articles